All Baystate hospitals, Emergency Departments and surgical services are open for care. Baystate medical practices and clinics will reopen for in-person care on Tuesday, February 24. Virtual care/telehealth remains available. Please click read more for any other updates on weather-related information.
For this sub-study, you will be assigned to treatment with talazoparib (BMN 673), a PARP inhibitor. The purpose of this sub-study is to find any good and bad effects of talazoparib (BMN 673). Talazoparib (BMN 673) may or may not shrink your cancer and it could also cause side effects.
